Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

ClinicalTrials.gov ID: NCT01871727

Public ClinicalTrials.gov record NCT01871727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Clinical Study to Demonstrate Safety and Efficacy of E7777 in Persistent or Recurrent Cutaneous T-Cell Lymphoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to assess the efficacy of E7777 in participants with recurrent or persistent Cutaneous T-Cell Lymphoma (CTCL) in Stage I - III participants as assessed by objective response rate (ORR). A lead-in dose-finding part was used to determine dose level 9 microgram per kilogram (mcg/kg) E7777 that is being used to test efficacy and safety.

Study identification

NCT ID
NCT01871727
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
112 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 30, 2013 (Actual)
Primary completion
Dec 6, 2021 (Actual)
Completion
Dec 14, 2021 (Actual)
Last update posted
Nov 13, 2024

2013 – 2021

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
University of Alabama at Birmingham, Dermatology at Whitaker Clinic Birmingham Alabama 35233 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
City of Hope Medical Center National Medical Center Duarte California 91010 —
UC Irvine Health-Chao Family Comprehensive Cancer Center Orange California 92868 —
Stanford University Cancer Center Stanford California 94305 —
Yale University Cancer Center New Haven Connecticut 06520 —
University of Florida Gainesville Florida 32610 —
H. Lee Moffitt Cancer Center Tampa Florida 33612 —
University of South Florida College of Medicine Tampa Florida 33612 —
Winship Cancer Institute of Emory University Atlanta Georgia 30322 —
Northwestern Memorial Hospital Chicago Illinois 60612 —
Rush University Medical Center Chicago Illinois 60612 —
Dana Farber Cancer Institute Boston Massachusetts 02215 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Columbia University Medical Center New York New York 10032 —
University of PittsburghMedical Center Presbyterian Shadyside Pittsburgh Pennsylvania 15213 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15219 —
The University of TX MD Anderson Cancer Center Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01871727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01871727 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →